METTL8 high expression was related to poor prognosis in Bladder Urothelial Carcinoma (BLCA), Kidney renal papillary cell carcinoma, Brain Lower Grade Glioma, LUAD and Thyroid carcinoma. Here, METTL8 is linked to thyroid gland carcinoma.